Under the terms of this letter of intent (LOI), IDL will develop and manufacture the product which will be marketed and distributed by Breckenridge.
The two companies plan to file an abbreviated new drug application with the FDA in early 2009.
Under the terms of this letter of intent (LOI), IDL will develop and manufacture the product which will be marketed and distributed by Breckenridge.
The two companies plan to file an abbreviated new drug application with the FDA in early 2009.